60
DAFTAR PUSTAKA
Adli, F. K. (2021) “Diabetes Melitus Gestasional : Diagnosis dan Faktor Risiko,”
Jurnal Medika Hutama, 03(01), hal. 1545–1551.
Akalu, Y. dan Belsti, Y. (2020) “Hypertension and its associated factors among type 2 diabetes mellitus patients at Debre Tabor general hospital, northwest Ethiopia,” Diabetes, Metabolic Syndrome and Obesity, 13, hal. 1621–1631.
doi: 10.2147/DMSO.S254537.
American Academy of Family Physicians., (2014) “JNC 8 Guidelines for The Management of Hypertension in Adult,” American Family Physician, 90(7), hal. 503–504. Tersedia pada: http://www.aafp.org/afp/2014/1001/p503.html.
Amin, M. Al dan Juniati, D. (2017) “Klasifikasi Kelompok Umur Manusia,”
MATHunesa, 2(6), hal. 34.
Anderson, G. (2023) “Type I Diabetes Pathoetiology and Pathophysiology: Roles of the Gut Microbiome, Pancreatic Cellular Interactions, and the ‘Bystander’
Activation of Memory CD8+ T Cells,” International Journal of Molecular Sciences, 24(4). doi: 10.3390/ijms24043300.
Antonetti, D. A. dan Silva, P. S. (2021) “Current understanding of the molecular and cellular pathology of diabetic retinopathy,” Nature Reviews Endocrinology, 17(April), hal. 195–206. doi: 10.1038/s41574-020-00451-4.
Arifin, H. et al. (2022) “Analysis of Modifiable, Non-Modifiable, and Physiological Risk Factors of Non-Communicable Diseases in Indonesia: Evidence from the 2018 Indonesian Basic Health Research,” Journal of Multidisciplinary Healthcare, 15(September), hal. 2203–2221. doi: 10.2147/JMDH.S382191.
Butler, A. E. dan Misselbrook, D. (2020) “Distinguishing between type 1 and type 2 diabetes,” hal. 1–3. doi: 10.1136/bmj.m2998.
Cleven, L. et al. (2020) “The association between physical activity with incident obesity, coronary heart disease, diabetes and hypertension in adults: A systematic review of longitudinal studies published after 2012,” BMC Public Health, 20(1), hal. 1–15. doi: 10.1186/s12889-020-08715-4.
Dyah Purnamasari (2018) “The Emergence of Non-communicable Disease in Indonesia | Purnamasari | Acta Medica Indonesiana,” Acta Med Indones - Indones J Intern Med, 50(4), hal. 273–274. Tersedia pada:
http://www.actamedindones.org/index.php/ijim/article/view/1028/339.
Eizirik, D. L. et al. (2020) “Pancreatic β-cells in type 1 and type 2 diabetes mellitus:
different pathways to failure,” Nature Reviews Endocrinology, 16(7), hal.
349–362. doi: 10.1038/s41574-020-0355-7.
Eyth, E., et al. (2023) Glucose Tolerance Test, StatPearls. Tersedia pada:
http://www.ncbi.nlm.nih.gov/pubmed/30949907.
Eyth, E. dan Naik, R. (2023) Hemoglobin A1C, StatPearls. Tersedia pada:
61
http://www.ncbi.nlm.nih.gov/pubmed/31411713.
Falufie J, M. R., et al. (2015) “Karakteristik Pasien Diabetes Mellitus Tipe 2 Komplikasi Hipertensi Di Rsud Abdul Wahab Sjahranie Samarinda Tahun 2012-2014,” in Proceeding of Mulawarman Pharmaceuticals Conferences.
Fakultas Farmasi, Universitas Mulawarman, Samarinda, hal. 39–42. doi:
10.25026/mpc.v2i1.37.
Feldman, E. L. et al. (2019) “Diabetic neuropathy,” Nature Reviews Disease Primers, 5(1). doi: 10.1038/s41572-019-0092-1.
Galicia-Garcia, U. et al. (2020) “Pathophysiology of type 2 diabetes mellitus,”
International Journal of Molecular Sciences, 21(17), hal. 1–34. doi:
10.3390/ijms21176275.
Hakim, M. D. F. L., et al.. (2019) “Karakteristik Pasien Rawat Jalan Diabetes Melitus Tipe II Komplikasi Hipertensi Esensial di RSUD Sultan Syarif Mohamad Alkadrie Pontianak,” Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN, vol 4(1), hal. 120.
Halim, M. dan Halim, A. (2019) “The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes),” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 13(2), hal. 1165–
1172. doi: 10.1016/j.dsx.2019.01.040.
Hardianto, D. (2021) “Telaah Komprehensif Diabetes Melitus: Klasifikasi, Gejala, Diagnosis, Pencegahan, Dan Pengobatan,” Jurnal Bioteknologi & Biosains Indonesia (JBBI), 7(2), hal. 304–317. doi: 10.29122/jbbi.v7i2.4209.
Huang, D. et al. (2017) “Macrovascular Complications in Patients with Diabetes and Prediabetes,” BioMed Research International, 2017, hal. 1–9. doi:
10.1155/2017/7839101.
Imelda, S. I. (2019) “Faktor-Faktor Yang Mempengaruhi Terjadinya diabetes Melitus di Puskesmas Harapan Raya Tahun 2018,” Scientia Journal, 8(1), hal. 28–39. doi: 10.35141/scj.v8i1.406.
Irawan, Q. P. et al. (2022) “Hubungan Indeks Massa Tubuh (IMT) dengan Kadar HbA1c pada Penderita Diabetes Mellitus Tipe II di Rumah Sakit Abdoel Wahab Sjahranie,” Formosa Journal of Science and Technology, 1(5), hal.
459–468. doi: 10.55927/fjst.v1i5.1220.
Ismail, L., et al. (2021) “Association of risk factors with type 2 diabetes: A systematic review,” Computational and Structural Biotechnology Journal, 19, hal. 1759–1785. doi: 10.1016/j.csbj.2021.03.003.
Kementrian Kesehatan Republik Indonesia (2018a) Laporan Nasional RISKESDAS 2018, Badan Penelitian dan Pengembangan Kesehatan. Tersedia pada:
http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/La poran_Nasional_RKD2018_FINAL.pdf.
Kementrian Kesehatan Republik Indonesia (2018b) Laporan Provinsi Bali RISKESDAS 2018, Badan Penelitian dan Pengembangan Kesehatan.
62
Kuwabara, M. et al. (2018) “Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects,” Nutrients, 10(8). doi: 10.3390/nu10081011.
Masriadi, M. et al. (2022) “Predictors that affect the Quality of Life Patient with Diabetes Mellitus: A Systematic Review,” Open Access Macedonian Journal of Medical Sciences, 10(F), hal. 340–344. doi: 10.3889/oamjms.2022.8887.
Naha, S. et al. (2021) Hypertension in Diabetes, Endotext. Tersedia pada:
http://www.ncbi.nlm.nih.gov/pubmed/14597461.
Naseri, M. W., et al. (2022) “Prevalence of hypertension in Type-2 diabetes mellitus,” Annals of Medicine and Surgery, 78(March), hal. 103758. doi:
10.1016/j.amsu.2022.103758.
Pardede, T., et al. (2017) “Gambaran Pengendalian Diabetes Melitus Berdasarkan Parameter Indeks Massa Tubuh dan Tekanan Darah di Poli Rawat Jalan Penyakit Dalam RSUD Arifin Achmad Pekanbaru,” Jurnal Online Mahasiswa Fakultas Kedokteran Universitas Riau, 4(1), hal. 1–14.
Perkumpulan Endokrinologi Indonesia (2021) “Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021,” hal. 11–12.
Tersedia pada: www.ginasthma.org.
Petersmann, A. et al. (2019) “Definition, Classification and Diagnosis of Diabetes Mellitus,” Experimental and Clinical Endocrinology and Diabetes, 127(Suppl 1), hal. S1–S7. doi: 10.1055/a-1018-9078.
Petrie, J. R., et al. (2018) “Diabetes, Hypertension, and Cardiovascular Disease:
Clinical Insights and Vascular Mechanisms,” Canadian Journal of Cardiology, 34(5), hal. 575–584. doi: 10.1016/j.cjca.2017.12.005.
Pratama Putra, I. D. G. I., et al. (2019) “Hubungan kadar gula darah dengan hipertensi pada pasien diabetes mellitus tipe 2 di RSUP Sanglah,” Intisari Sains Medis, 10(3), hal. 797–800. doi: 10.15562/ism.v10i3.482.
Putra, A. A. G. M. dan Saraswati, M. R. (2021) “Prevalensi Diabetes Melitus Tipe 2 Dengan Hipertensi Di RSUP Sanglah Denpasar Tahun 2015 Bagian Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Udayana Diabetes melitus ( DM ) tipe 2 ditandai oleh kondisi medis yakni meningkatnya kadar gula darah mele,” ISSN: 2597-8012 Jurnal Medika Udayana, VOL. 10 NO.6,Juni, 2021, 10(6), hal. 61–63.
Rahman, M. S. et al. (2021) “Role of insulin in health and disease: An update,”
International Journal of Molecular Sciences, 22(12), hal. 1–19. doi:
10.3390/ijms22126403.
Rewers, M., et al. (2015) “Chapter 11: Risk Factors for Type 1 Diabetes,” Diabetes in America, (3), hal. 11–29.
Roep, B. O. et al. (2021) “Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?),” Nature Reviews Endocrinology, 17(3), hal.
150–161. doi: 10.1038/s41574-020-00443-4.
63
Sabrini, A. M., et al. (2022) “Karakteristik Pasien Dm Tipe 2 Dengan Hipertensi Di Poliklinik Penyakit Dalam Rsud Raden Mattaher Jambi Tahun 2016- 2019,” Joms, 2(2), hal. 72–80.
Sagoo, M. dan Gnudi, L. (2020) Diabetic Nephropathy, Diabetic Nephropathy.
Diedit oleh L. Gnudi dan D. A. Long. New York, NY: Springer US (Methods in Molecular Biology). doi: 10.1007/978-1-4939-9841-8.
Saibi, Y. et al. (2020) “Potensi Hipoglikemia dan Hiperglikemia pada Pasien Diabetes Melitus Tipe 2 Akibat Interaksi Obat,” Jurnal Ilmiah Ibnu Sina (JIIS) Ilmu Farmasi dan Kesehatan, 5(2), hal. 258–267. doi:
10.36387/jiis.v5i2.468.
Samsu, N. (2021) “Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.,” BioMed research international, 2021, hal. 1497449. doi:
10.1155/2021/1497449.
Simkova, S. S., et al. (2022) “Assessment of healthy lifestyles in relation to BMI.,”
Neuro endocrinology letters, 43(7–8), hal. 393–399. Tersedia pada:
http://www.ncbi.nlm.nih.gov/pubmed/36720128.
Solomon, S. D. et al. (2017) “Diabetic retinopathy: A position statement by the American Diabetes Association,” Diabetes Care, 40(3), hal. 412–418. doi:
10.2337/dc16-2641.
Suastika, K. et al. (2012) “Age is an Important Risk Factor for Type 2 Diabetes Mellitus and Cardiovascular Diseases,” in Glucose Tolerance. InTech, hal.
13. doi: 10.5772/52397.
Taylor, R. dan Holman, R. R. (2015) “Normal weight individuals who develop Type 2 diabetes: The personal fat threshold,” Clinical Science, 128(7), hal.
405–410. doi: 10.1042/CS20140553.
Whelton, P. K. et al. (2018) “2017 ACC/AHA/ AAPA/ ABC/ACPM/ AGS/APhA/
ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Pr,” Hypertension, 71(6). doi: 10.1161/HYP.0000000000000065.
World Health Organization (2000) “The Asia-Pacific perspective : redefining obesity and its treatment,” hal. 8–45.
World Health Organization (2022) Diabetes. Tersedia pada:
https://www.who.int/news-room/fact-sheets/detail/diabetes.
